RxDoctor Payments Data

Laneshia Patrick

Adult Health · Jacksonville, NCNPI 1942690847

Payments from drug & device makers

$563in general payments, 2019–2025

Across 30 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Forte Bio-pharma LLC$155
  • Scilex Pharmaceuticals Inc.$123
  • Boston Scientific$103
  • Protega Pharmaceutials Inc$55
  • Valinor Pharma, LLC$38
  • Azurity Pharmaceuticals, Inc.$31
  • plus $59 from 3 others

What the payments were for

  • Food & beverage$563100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Forte Bio-pharma LLC8$155
Scilex Pharmaceuticals Inc.7$123
Boston Scientific6$103
Protega Pharmaceutials Inc2$55
Valinor Pharma, LLC2$38
Azurity Pharmaceuticals, Inc.2$31
Abbott1$24
Lundbeck LLC1$23
Biodelivery Sciences International, Inc.1$12

How this compares

$563 in reported general payments places this provider in the 55th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$77,200
Medicare patients
64
Services billed
880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen613$29,328
HorizantGabapentin Enacarbil20$18,837
Oxycodone Hcl637$14,001
OxycontinOxycodone Hcl27$11,780
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen284$10,257
ZtlidoLidocaine19$7,399
LinzessLinaclotide11$5,988
Lidocaine50$5,216
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$3,032
Diclofenac Sodium26$2,965
SuboxoneBuprenorphine Hcl/Naloxone Hcl12$2,954
Pregabalin105$2,707
Tizanidine Hcl188$2,452
Gabapentin187$2,275
Morphine Sulfate ErMorphine Sulfate38$1,936

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$123$7,39919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 614 adult health providers in North Carolina.

Other adult health in Jacksonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →